Andean Precious Metals Corp. (CVE:APM – Get Free Report) Senior Officer Juan Carlos Sandoval Amare bought 31,300 shares of the business’s stock in a transaction dated Friday, January 3rd. The shares were bought at an average cost of C$1.21 per share, for a total transaction of C$37,860.48.
Andean Precious Metals Trading Down 1.7 %
CVE:APM opened at C$1.17 on Tuesday. The firm has a market capitalization of C$174.75 million, a price-to-earnings ratio of 3.08 and a beta of 1.22. Andean Precious Metals Corp. has a 1-year low of C$0.57 and a 1-year high of C$2.18. The business’s fifty day moving average price is C$1.36 and its 200 day moving average price is C$1.26.
Analysts Set New Price Targets
Separately, Desjardins raised Andean Precious Metals to a “moderate buy” rating in a research report on Thursday, October 31st.
Andean Precious Metals Company Profile
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
Featured Articles
- Five stocks we like better than Andean Precious Metals
- Investing in Travel Stocks Benefits
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Compound Interest and Why It Matters When Investing
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.
